Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger Buckley

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 14, 2013
Improved wait time intervals for prostate cancer patients in a multidisciplinary rapid diagnostic unit compared to a community-based referral patternPerakaa Sethukavalan, Liying Zhang, Vibhuti Jethava, et al.
The Canadian Journal of Urology|March 7, 2017
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approachAndrew Loblaw, Jack Barkin, Roger Buckley, et al.
The Journal of Urology|October 22, 2011
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer GroupMaurizio Brausi, J Alfred Witjes, Donald Lamm, et al.
BJU International|March 5, 2013
Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS)J Alfred Witjes, Joan Palou, Mark Soloway, et al.
The Journal of Urology|April 1, 2014
Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancerAshish M Kamat, J Alfred Witjes, Maurizio Brausi, et al.
The Journal of Urology|August 27, 2013
Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definitionDonald Lamm, Raj Persad, Maurizio Brausi, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment programDavid Guy, Gabriella Ghanem, Andrew Loblaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer GroupAshish M Kamat, Richard J Sylvester, Andreas Böhle, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|September 14, 2013
Improved wait time intervals for prostate cancer patients in a multidisciplinary rapid diagnostic unit compared to a community-based referral patternPerakaa Sethukavalan, Liying Zhang, Vibhuti Jethava, et al.
The Canadian Journal of Urology|March 7, 2017
Improving prostate cancer care collaboratively - a multidisciplinary, formal, consensus-based approachAndrew Loblaw, Jack Barkin, Roger Buckley, et al.
The Journal of Urology|October 22, 2011
A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer GroupMaurizio Brausi, J Alfred Witjes, Donald Lamm, et al.
BJU International|March 5, 2013
Current clinical practice gaps in the treatment of intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC) with emphasis on the use of bacillus Calmette-Guérin (BCG): results of an international individual patient data survey (IPDS)J Alfred Witjes, Joan Palou, Mark Soloway, et al.
The Journal of Urology|April 1, 2014
Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancerAshish M Kamat, J Alfred Witjes, Maurizio Brausi, et al.
The Journal of Urology|August 27, 2013
Defining progression in nonmuscle invasive bladder cancer: it is time for a new, standard definitionDonald Lamm, Raj Persad, Maurizio Brausi, et al.
Nature Reviews. Urology|March 2, 2017
BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCGAshish M Kamat, Marc Colombel, Debasish Sundi, et al.
BJU International|January 18, 2020
Risk-adapted management of low-grade bladder tumours: recommendations from the International Bladder Cancer Group (IBCG)Justin T Matulay, Mark Soloway, J Alfred Witjes, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 25, 2016
Diagnosis, referral, and primary treatment decisions in newly diagnosed prostate cancer patients in a multidisciplinary diagnostic assessment programDavid Guy, Gabriella Ghanem, Andrew Loblaw, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Definitions, End Points, and Clinical Trial Designs for Non-Muscle-Invasive Bladder Cancer: Recommendations From the International Bladder Cancer GroupAshish M Kamat, Richard J Sylvester, Andreas Böhle, et al.
Pageof 3